Together, These Meds Might Be Dangerous
[ad_1] (RxWiki News) What do you get when you mix strong painkillers with medications for anxiety? You might get a raised risk of overdose, according to a new study. This
New Parkinson’s Rx Gets FDA Nod
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved an add-on therapy for patients with Parkinson’s disease. The FDA approved Xadago (safinamide) tablets for use in patients who
Keytruda Gets a New Job
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has granted accelerated approval to pembrolizumab (brand name Keytruda) for patients with classical Hodgkin lymphoma (cHL). Pembrolizumab was approved for
FDA OKs Rx for 'Smile Lines'
[ad_1] The US Food and Drug Administration has approved Allergan’s Juvederm Vollure XC for use in combating moderate to severe facial wrinkles and folds. [ad_2] Source link
FDA Warns About IBS Rx Complication
[ad_1] (RxWiki News) If you’ve had your gallbladder removed, the US Food and Drug Administration (FDA) is warning that you shouldn’t use a particular irritable bowel syndrome medication. According to
AFib Rx Could Prevent More Strokes
[ad_1] (RxWiki News) More than 80 percent of people with atrial fibrillation (AFib) who had a stroke had not been prescribed adequate blood-thinning medication, a new study found. And that
How Screen Time Might Affect Children’s Health
[ad_1] (RxWiki News) Kids who get three or more hours of screen time each day may face a raised risk of diabetes, a new study found. Children who spend too much
Not All Nursery Products Are Safe
[ad_1] (RxWiki News) Nursery products like baby carriers may be responsible for an increasing number of injuries to young children, a new study found. In fact, the authors of this
Your Kids Might Extend Your Life
[ad_1] (RxWiki News) Being a parent could extend your life, according to a new study. Compared to those without children, parents may live as much as two years longer, this
New Breast Cancer Rx Approved
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat breast cancer. This new approval can be found under the name Kisqali (ribociclib). The FDA